Home
>
National Drug Code (NDC)
>
Piroxicam
Piroxicam - 29033-013-05 - (Piroxicam)
Drug Information of Piroxicam
| Product NDC: | 29033-013 |
| Proprietary Name: | Piroxicam |
| Non Proprietary Name: | Piroxicam |
| Active Ingredient(s): | 20 mg/1 & nbsp; Piroxicam |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Piroxicam
| Product NDC: | 29033-013 |
| Labeler Name: | Nostrum Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074118 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20100105 |
Package Information of Piroxicam
| Package NDC: | 29033-013-05 |
| Package Description: | 500 CAPSULE in 1 BOTTLE, PLASTIC (29033-013-05) |
NDC Information of Piroxicam
| NDC Code | 29033-013-05 |
| Proprietary Name | Piroxicam |
| Package Description | 500 CAPSULE in 1 BOTTLE, PLASTIC (29033-013-05) |
| Product NDC | 29033-013 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Piroxicam |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20100105 |
| Marketing Category Name | ANDA |
| Labeler Name | Nostrum Laboratories, Inc. |
| Substance Name | PIROXICAM |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
